Saint Lucia vs Tonga: The number of people with susceptibility test result for rifampicin
Saint Lucia
2
in 2021
Tonga
7
in 2021
Saint Lucia rank
143rd
Tonga rank
141st
The number of people with susceptibility test result for rifampicin over time
- Saint Lucia
- Tonga
How they compare
Tonga currently reports 7 against 2 in Saint Lucia, a difference of 5.
That makes Tonga's figure about 3.5 times Saint Lucia's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Saint Lucia ahead.
Saint Lucia ranks 143rd and Tonga ranks 141st of 155 countries.
Tonga has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Lucia | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5 | 6 | 1 | Tonga |
| 2020s | 2.5 | 6 | 3.5 | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Saint Lucia or Tonga?
- Tonga, at 7 against 2 in Saint Lucia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Saint Lucia and Tonga?
- 5, with Tonga ahead.
- How many years of comparable data are there for Saint Lucia and Tonga?
- 5 years are reported by both, from 2017 to 2021.
- How do Saint Lucia and Tonga rank globally for the number of people with susceptibility test result for rifampicin?
- Saint Lucia ranks 143rd and Tonga ranks 141st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.